[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350940-105":59,"doc-detail-350940-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","global-surge-in-pancreatic-cancer-cases-driven-by-ageing-populations-and-modifiable-risks-research-report","Global surge in pancreatic cancer cases driven by ageing populations and modifiable risks - Research report","","Global surge in pancreatic cancer cases driven by ageing populations and modifiable risks analyzes pancreatic cancer epidemiology, lifestyle-related contributors, and long-term projections. Using 2022 Global Cancer Observatory data, incidence, mortality, 5-year prevalence, and mortality-incidence ratio are estimated, while modifiable risks are modeled from Global Health Observatory information. Temporal trends are evaluated via estimated annual percentage changes stratified by age and gender, with projections from 2022–2050 informing regional and sex-specific priorities.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/global-surge-in-pancreatic-cancer-cases-driven-by-ageing-populations-and-modifiable-risks-research-report/350940/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/global-surge-in-pancreatic-cancer-cases-driven-by-ageing-populations-and-modifiable-risks-research-report/350940.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What data sources are used to estimate pancreatic cancer outcomes in this study?","Question",{"text":113,"@type":114},"The study uses 2022 data from the Global Cancer Observatory (GCO) to estimate incidence, mortality, 5-year prevalence, and the mortality-incidence-ratio. Modifiable risk factors are extracted from the Global Health Observatory (GHO).","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which regions and demographic groups show the highest pancreatic cancer burden in 2022?",{"text":118,"@type":114},"In 2022, Northern America and Europe have the highest pancreatic cancer burden. Males are consistently affected more than females, and older females show an observed increase in pancreatic cancer mortality.",{"name":120,"@type":111,"acceptedAnswer":121},"What do the projections suggest about future elderly pancreatic cancer cases and mortality growth?",{"text":122,"@type":114},"Projections indicate an 85–91% increase in elderly pancreatic cancer cases by 2050. Asia faces the greatest estimated number of new cases, while Africa is estimated to have the fastest mortality growth (159.2%).","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},350940,1790120023,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Electronic supplementary material:  \nThe online version of this article contains supplementary material.  \n© 2026 The Author(s)  \nCite as: Zheng W, Jiang G, Jolaoluwa O, Zhang Z, Song D, Ding Y, Feng J, Xu Y, Xu D, Zhao H, Zhang L, Ji G, Lu L. Global surge in pancreatic cancer cases driven by ageing populations and modifiable risks. J Glob Health. 2026;16:04032 .  \nGlobal surge in pancreatic cancer cases driven by ageing populations and modifiable risks  \nWanyi Zheng1*, Guojia Jiang1*, Jolaoluwa Grace Oparinde1,  \nZiqi Zhang2, Deji Song2, Yi Ding2, Jiayun Feng1, Youyan Xu1,  \nDanni Xu1, Hailei Zhao1, Li Zhang2,3,  \nGuang Ji2,3, Lili Lu1  \n1Shanghai University of Traditional Chinese Medicine, School of Public Health, Shanghai, China 2 Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Institute of Digestive Diseases, Shanghai, China 3State Key Laboratory of Integration and Innovation of Classical Formula and Modern Chinese Medicine, Shanghai, China  \n*Joint first authorship.  \nCorrespondence to:  \nLili Lu  \nShanghai University of Traditional Chinese Medicine, School of Public Health  \nCailun Road No. 1200, Pudong New District, Shanghai, China [lililu@shutcm.edu.cn](lililu@shutcm.edu.cn)  \nGuang Ji  \nLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Institute of Digestive Diseases; State Key Laboratory of Integration and Innovation of Classical Formula and Modern Chinese Medicine  \nSouth Wanping Road No.725, Xuhui District, Shanghai, China [jiliver@vip.sina.com](jiliver@vip.sina.com)  \nBackground Pancreatic cancer (PC) ranks among the most lethal malignant neoplasms, primarily due to its late-stage diagnosis and lack of available therapeutic modalities. This study aimed to characterise the current PC epidemiological profiles, lifestyle-related contributors, and projections to unveil its global disease burden .  \nMethods Using 2022 data from the Global Cancer Observatory (GCO), we estimated PC incidence, mortality, 5-year prevalence, and mortality-incidence-ratio. Modifiable risk factors were extracted from the Global Health Observatory to identify its predictive model. The temporal trends were assessed via estimated annual percentage changes (EAPCs) stratified by age and gender, and the future projection was also collected from GCO, 2022–2050, estimated number of new cases and deaths data .  \nResults In 2022, Northern America and Europe had the highest PC burden, with males consistently affected more than females . Alarmingly, a concerning increase in PC mortality was observed among older females . Projections indicate an 85–91% increase in elderly PC cases by 2050, with Asia facing the greatest challenge (487 087 estimated new cases) and Africa being estimated with the fastest mortality growth (159.2%) . Strong positive correlations were observed between PC prevalence and human development index (HDI), as well as lifestyle factors e.g. raised total cholesterol (correlation coefficient (r) = 0 .695, P\u003C 0 .001), cigarette smoking (r= 0 .528, P\u003C 0 .001), and alcohol drinking (r= 0 .505, P\u003C 0 .001) .  \nConclusions This research underlines the urgent need for region-specific interventions, not only for Northern America and Europe, which currently bear a high PC burden, but also for high-risk populations like Asia and Africa . The projected 85– 91% rise in elderly PC cases by 2050, coupled with emerging risks in young females (incidence rose in n/N = 39/52 countries), demands prioritised research on modifiable factors and sex-tailored prevention strategies. These discoveries call for global action to mitigate the escalating PC burden through demographic-targeted public health measures .  \nPancreatic cancer (PC) is among the most lethal malignant neoplasms with a reported ever-rising incidence and prevalence, as well as an overall 5-year survival rate of merely 12%[1]. Lack of specific symptoms at the preliminary stage and feasible population-based screening programmes contribute to its late di","cbCaipLshhfA1YUs","https://ap.wps.com/l/cbCaipLshhfA1YUs","pdf",1752712,15,"English","# Background\n# Methods\n# Results\n# Conclusions\n# References and evidence notes","[{\"question\":\"What data sources are used to estimate pancreatic cancer outcomes in this study?\",\"answer\":\"The study uses 2022 data from the Global Cancer Observatory (GCO) to estimate incidence, mortality, 5-year prevalence, and the mortality-incidence-ratio. Modifiable risk factors are extracted from the Global Health Observatory (GHO).\"},{\"question\":\"Which regions and demographic groups show the highest pancreatic cancer burden in 2022?\",\"answer\":\"In 2022, Northern America and Europe have the highest pancreatic cancer burden. Males are consistently affected more than females, and older females show an observed increase in pancreatic cancer mortality.\"},{\"question\":\"What do the projections suggest about future elderly pancreatic cancer cases and mortality growth?\",\"answer\":\"Projections indicate an 85–91% increase in elderly pancreatic cancer cases by 2050. Asia faces the greatest estimated number of new cases, while Africa is estimated to have the fastest mortality growth (159.2%).\"}]","Global surge in pancreatic cancer cases driven by ageing populations and modifiable risks - Research report | PDF",1790091896,38,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1dec3f9757d6c782a4603c9f4498d1f7.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8d3a090764bda7093ec148804938bc3f.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2013f6f2dec77b64892f94aff510e624.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3bb4e0299f94f5bc0183afae797c3fa1.webp",980,1306]